• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LVAS IMPLANT KIT; VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 106524US
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Arrhythmia (1721); Respiratory Distress (2045); Right Ventricular Dysfunction (2054)
Event Date 04/29/2020
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
It was reported that patient was admitted on (b)(6) 2020 from community emergency department (ed) for incessant ventricular tachycardia (vt), for which patient's implantable cardioverter-defibrillator (icd) failed to shock him.After admit to cardiovascular intensive care unit (cvicu), direct current cardioversion (dcc) was performed and patient was returned to normal sinus rhythm (nsr).Patient underwent a right heart catheterization (rhc) on (b)(6) 2020 and discovered mod right ventricular (rv) dysfunction (unchanged from preimplant) and normal cardiac output (co) and cardiac index (ci).Due to return to vt, a bilateral sympathectomy was performed on (b)(6) 2020, but patient continued with vt post-procedure and required conversion.His amiodarone was increased.On (b)(6) 2020, patient experienced a hypoxic respiratory arrest, believed to be rv related by his care team, and was intubated (b)(6) 2020 - (b)(6) 2020.Since that event, he experienced delirium and failed swallow study.The are continuing with supportive measures.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct correlation between the device and the reported ventricular tachycardia, right ventricle dysfunction, hypoxic respiratory arrest, and neurological issues following intubation could not be determined through this evaluation.However, it was reported that the patient's right ventricle dysfunction was a preexisting condition and was unchanged from preimplant.It was reported that the patient was directly admitted on (b)(6) 2020 (approximately 4 months post-implant) from the community emergency department for incessant ventricular tachycardia (vt), for which the patient's implantable cardioverter defibrillator (icd) failed to shock him.After admission to the cardiovascular intensive care unit (cvicu), direct current conversion (dcc) was performed and the patient was returned to normal sinus rhythm (nsr).The patient underwent a right heart catheterization (rhc) on (b)(6) 2020, which revealed moderate right ventricle (rv) dysfunction with normal cardiac output (co) and cardiac index (ci).It was reported that the patient¿s rv dysfunction was unchanged from preimplant.Information provided indicated that a bilateral sympathectomy was performed on (b)(6)2020 due to recurring vt, but the patient continued to experience vt post-procedure and required conversion.His amiodarone dosage was also increased.The patient then experienced a hypoxic respiratory arrest on (b)(6) 2020, which was believed to be rv related by his care team.The patient was intubated from (b)(6) 2020.Since that event, he experienced delirium and failed a swallow study.The center continued with supportive measures.No alarms or functional issues with the lvas were reported in association with the event.The patient remains ongoing on (b)(6) and no additional events have been reported at this time.The heartmate 3 lvas ifu lists cardiac arrhythmia, right heart failure, respiratory failure, and other neurological event (not stroke-related) as adverse events that may be associated with the use of the heartmate 3 left ventricular assist system.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LVAS IMPLANT KIT
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key10158769
MDR Text Key196934767
Report Number2916596-2020-03103
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public00813024013297
Combination Product (y/n)N
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 08/31/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date02/21/2022
Device Model Number106524US
Device Catalogue Number106524US
Device Lot Number7275033
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received08/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age69 YR
Patient Weight95
-
-